BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

Arctic Vision to develop innovative therapies for pan-ocular diseases

Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today...

July 05, 2021 | News

RauCon Signs Second Partnership Agreement for Chinese Pharma Market

According to the agreements, RauCon will promote both companies’ service offers while Ling med and GBI will promote RauCon’s Marketplaces for P...

July 02, 2021 | News

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio

First patient dosed in U.S. phase 1 clinical trial of TJ-CD4B/ABL111 in patients with advanced or metastatic solid tumors China sites to join the d...

July 02, 2021 | News

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

OnCusp successfully closed its seed round financing of $25 million on April 1, 2021, led by Sequoia Capital and Biotrack Capital, followed b...

July 01, 2021 | News

Clover Announces Advance Purchase Agreement with Gavi

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...

June 30, 2021 | News

Innovent Announces An Agreement with Synaffix

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

June 29, 2021 | News

The Third Asia Pacific Psychiatry Symposium Takes Place

The global COVID-19 pandemic poses a serious threat to physical health and has wide-ranging implications for mental health worldwide. At the third Asia Pac...

June 29, 2021 | News

Peijia Medical leads China into the "Retrievable Era" using TAVR products

The TaurusElite® Transcatheter Aortic Valve Replacement System (hereinafter referred to as "TaurusElite®") developed by Peijia Medical (9996.H...

June 28, 2021 | News

China's Public Health System Primed for Digital Innovation

China's Public Health System Primed for Digital Innovation Online/Offline Service Delivery 'Huge Growth Opportunity', says Ping An Co-CEO Ms. Tan ...

June 26, 2021 | News

Zuellig Pharma to advance Cyber-intelligence Capabilities

Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture CYFIRMA, a threat discovery and cyb...

June 25, 2021 | News

China's first CAR-T Cell Therapy (FKC876) approved

The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetica...

June 24, 2021 | News

Endurance RP A New Perspective Eye on China's fertility and longevity market

Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to annou...

June 24, 2021 | News

Chinese Bioheng Biotech received ODD from the U.S. FDA

"CTD401 is the first innovative product based on our next-generation generic CAR-T technology platform. It has excellent efficacy and superior safety in ex...

June 21, 2021 | News

Malaysia Granted Permission for COVID-19 Test Kit from China for Emergency Use

Amid rising concerns about the threat and economic impact of COVID-19, Holista Colltech Limited has been granted permission for Special access under the Me...

June 18, 2021 | News

Stay Connected